November 30, 1999Merck and Company Aldoril D50
West Point, PA (SafetyAlerts) - The Food and Drug
Administration (FDA) today reported that Merck and Company is recalling Aldoril D50
Tablets, (Methyldopa (500mg)-Hydro-chlorothiazide (50mg)), in 100 Tablet bottles, a Rx
used to control hypertension with the NDC #0006-0935-68, because of dissolution failure
This ongoing Class III recall was initiated
by the company, September 23, 1999 by letter. This is the first notice the FDA has
issued to the general public of the recall.
Over 15,000 bottles were distributed
nationwide and bear the lot numbers and expiration dates of B5511 EXP 1/00, D5714 EXP
4/00, D5719 EXP 4/00, E6156 EXP 4/00, E6172 EXP 2/00 or H3896 EXP 4/00.
Questions concerning this recall may
be directed to the FDA at 1-888-INFO-FDA.
Safety Alerts compiles
comprehensive safety recall information for the United States. SafeMail is a free email
service to warn consumers of faulty products and contaminated foods. For complete
information regarding current recalls, past recalls and timely product warning
notification visit: www.safetyalerts.com.